Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunotherapy”

551 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 551 results

Very early researchStudy completedNCT03387553
What this trial is testing

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer, Male+5 more
H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableStudy completedNCT06453395
What this trial is testing

PPIO-009 Tumor Regression Grade and Tumor Location in Esophageal Cancer

Who this might be right for
Tumor Regression Grade
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 248
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817095
What this trial is testing

SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Undifferentiated Pleomorphic Sarcoma (UPS)
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938609
What this trial is testing

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Providence Health & Services 28
Testing effectiveness (Phase 2)Looking for participantsNCT06492421
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Who this might be right for
Lung CancerSurgeryNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612098
What this trial is testing

Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 274
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Looking for participantsNCT03842943
What this trial is testing

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Who this might be right for
Cutaneous Melanoma
University of Louisville 28
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Not applicableUnknownNCT04913896
What this trial is testing

CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

Who this might be right for
Gastric CancerMagnetic Resonance ImagingTomography, X-Ray Computed+2 more
The First Hospital of Jilin University 200
Testing effectiveness (Phase 2)Looking for participantsNCT07387198
What this trial is testing

Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab

Who this might be right for
Merkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage IINeoadjuvant Immunotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 135
Testing effectiveness (Phase 2)Active Not RecruitingNCT05176002
What this trial is testing

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Who this might be right for
Esophageal NeoplasmImmunotherapyRadiotherapy
Fujian Medical University Union Hospital 25
Testing effectiveness (Phase 2)UnknownNCT05387681
What this trial is testing

Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric

Who this might be right for
Gastric/Gastroesophageal Junction AdenocarcinomaRadiotherapyImmunotherapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Large-scale testing (Phase 3)Study completedNCT05215379
What this trial is testing

Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

Who this might be right for
Neoadjuvant Chemoradiation TherapyRectal CancerImmunotherapy+1 more
Changhai Hospital 201
Not applicableUnknownNCT06196554
What this trial is testing

Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs

Who this might be right for
Gastric CancerOrganoidNeoadjuvant Therapy
Dong Bing Zhao 40
Testing effectiveness (Phase 2)Looking for participantsNCT05800340
What this trial is testing

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Who this might be right for
Non-Small Cell Lung CancerRET Driver MutationBRAF V600 Mutation+3 more
Guangdong Provincial People's Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06407310
What this trial is testing

Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Tel Aviv Medical Center 25
Next Page